Levothyroxine sodium
- Product NDC
- 72789-297
- Requested package NDC
- 72789-297-30
- 11-digit product format
- 727890297
- Labeler code
- 72789
- Product ID
- 72789-297_4bae1773-79fb-e98a-e063-6394a90a3266
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Levothyroxine Sodium
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Application
- ANDA212399
- Marketing category
- ANDA
- Marketing start
- 2020-12-10
- Substance
- LEVOTHYROXINE SODIUM
- Active strength
- 100 ug/1
- Pharmacologic classes
- Thyroxine [CS], l-Thyroxine [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A212399-001 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | |
| A212399-002 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | |
| A212399-003 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | |
| A212399-004 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | |
| A212399-005 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | |
| A212399-006 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | |
| A212399-007 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | |
| A212399-008 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | |
| A212399-009 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | |
| A212399-010 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | |
| A212399-011 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | |
| A212399-012 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A212399-001 | AB1 |
| A212399-001 | AB2 |
| A212399-001 | AB3 |
| A212399-001 | AB4 |
| A212399-002 | AB1 |
| A212399-002 | AB2 |
| A212399-002 | AB3 |
| A212399-002 | AB4 |
| A212399-003 | AB1 |
| A212399-003 | AB2 |
| A212399-003 | AB3 |
| A212399-003 | AB4 |
| A212399-004 | AB1 |
| A212399-004 | AB2 |
| A212399-004 | AB3 |
| A212399-004 | AB4 |
| A212399-005 | AB1 |
| A212399-005 | AB2 |
| A212399-005 | AB3 |
| A212399-005 | AB4 |
| A212399-006 | AB1 |
| A212399-006 | AB2 |
| A212399-006 | AB3 |
| A212399-006 | AB4 |
| A212399-007 | AB1 |
| A212399-007 | AB2 |
| A212399-007 | AB3 |
| A212399-007 | AB4 |
| A212399-008 | AB1 |
| A212399-008 | AB2 |
| A212399-008 | AB3 |
| A212399-008 | AB4 |
| A212399-009 | AB1 |
| A212399-009 | AB2 |
| A212399-009 | AB3 |
| A212399-009 | AB4 |
| A212399-010 | AB1 |
| A212399-010 | AB2 |
| A212399-010 | AB3 |
| A212399-010 | AB4 |
| A212399-011 | AB1 |
| A212399-011 | AB2 |
| A212399-011 | AB3 |
| A212399-011 | AB4 |
| A212399-012 | AB1 |
| A212399-012 | AB2 |
| A212399-012 | AB3 |
| A212399-012 | AB4 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A212399-001 | LEVOTHYROXINE SODIUM | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A212399-002 | LEVOTHYROXINE SODIUM | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A212399-003 | LEVOTHYROXINE SODIUM | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A212399-004 | LEVOTHYROXINE SODIUM | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A212399-005 | LEVOTHYROXINE SODIUM | 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A212399-006 | LEVOTHYROXINE SODIUM | 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A212399-007 | LEVOTHYROXINE SODIUM | 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A212399-008 | LEVOTHYROXINE SODIUM | 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A212399-009 | LEVOTHYROXINE SODIUM | 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A212399-010 | LEVOTHYROXINE SODIUM | 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A212399-011 | LEVOTHYROXINE SODIUM | 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A212399-012 | LEVOTHYROXINE SODIUM | 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212399-001 | LEVOTHYROXINE SODIUM | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212399-002 | LEVOTHYROXINE SODIUM | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212399-003 | LEVOTHYROXINE SODIUM | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212399-004 | LEVOTHYROXINE SODIUM | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212399-005 | LEVOTHYROXINE SODIUM | 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212399-006 | LEVOTHYROXINE SODIUM | 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212399-007 | LEVOTHYROXINE SODIUM | 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212399-008 | LEVOTHYROXINE SODIUM | 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212399-009 | LEVOTHYROXINE SODIUM | 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212399-010 | LEVOTHYROXINE SODIUM | 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212399-011 | LEVOTHYROXINE SODIUM | 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212399-012 | LEVOTHYROXINE SODIUM | 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A212399-001 | LEVOTHYROXINE SODIUM | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A212399-002 | LEVOTHYROXINE SODIUM | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A212399-003 | LEVOTHYROXINE SODIUM | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A212399-004 | LEVOTHYROXINE SODIUM | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A212399-005 | LEVOTHYROXINE SODIUM | 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A212399-006 | LEVOTHYROXINE SODIUM | 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A212399-007 | LEVOTHYROXINE SODIUM | 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A212399-008 | LEVOTHYROXINE SODIUM | 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A212399-009 | LEVOTHYROXINE SODIUM | 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A212399-010 | LEVOTHYROXINE SODIUM | 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A212399-011 | LEVOTHYROXINE SODIUM | 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A212399-012 | LEVOTHYROXINE SODIUM | 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A212399-001 | LEVOTHYROXINE SODIUM | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A212399-002 | LEVOTHYROXINE SODIUM | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A212399-003 | LEVOTHYROXINE SODIUM | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A212399-004 | LEVOTHYROXINE SODIUM | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | fd3edfee7708… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A212399-001 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A212399-001 | AB2 | 2 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A212399-001 | AB3 | 3 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A212399-001 | AB4 | 4 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A212399-002 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A212399-002 | AB2 | 2 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A212399-002 | AB3 | 3 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A212399-002 | AB4 | 4 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A212399-003 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A212399-003 | AB2 | 2 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A212399-003 | AB3 | 3 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A212399-003 | AB4 | 4 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A212399-004 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A212399-004 | AB2 | 2 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A212399-004 | AB3 | 3 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A212399-004 | AB4 | 4 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A212399-005 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A212399-005 | AB2 | 2 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A212399-005 | AB3 | 3 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A212399-005 | AB4 | 4 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A212399-006 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A212399-006 | AB2 | 2 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A212399-006 | AB3 | 3 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A212399-006 | AB4 | 4 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A212399-007 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A212399-007 | AB2 | 2 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A212399-007 | AB3 | 3 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A212399-007 | AB4 | 4 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A212399-008 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A212399-008 | AB2 | 2 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A212399-008 | AB3 | 3 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A212399-008 | AB4 | 4 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A212399-009 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A212399-009 | AB2 | 2 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A212399-009 | AB3 | 3 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A212399-009 | AB4 | 4 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A212399-010 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A212399-010 | AB2 | 2 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A212399-010 | AB3 | 3 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A212399-010 | AB4 | 4 | 011fe1cb6892… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Levothyroxine sodium
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| LEVOTHYROXINE SODIUM | 100 ug/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 9J765S329G | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 892246 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 6f4998ac-0714-4f5d-8944-9e6902b9f0a6 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 97c252d3-9bb8-4530-bb44-9824dc7cf556 | Product name | 6 | 20250729 |
| 6c43b71c-35e6-4db3-ba24-c6ef42ff7003 | Product name | 3 | 20240207 |
| 890fd4bf-1a80-42b7-be1b-2d0259d5f0c8 | Product name | 5 | 20240207 |
| c8ad26bf-af73-460b-b74e-1eff16cc4f9f | Product name | 5 | 20240207 |
| e2db08c6-133f-4f4f-afb4-e90a2418d6f6 | Product name | 1 | 20230320 |
| 01383843-4069-43cf-aa76-dc17a6f9f8c4 | Product name | 2 | 20230123 |
| 978cca7d-a938-4791-8322-da48d90a63ef | Product name | 1 | 20230113 |
| 65f86ba3-8816-4e12-899b-18290c8de551 | Product name | 2 | 20210614 |
| f16ab90f-08c2-40be-a543-66d9827cd1f3 | Product name | 1 | 20210601 |
| 6a33ec05-2ae2-45e5-ab82-2d94b3303923 | Product name | 1 | 20190709 |
| 93355a10-1c44-4c92-a11d-7d995e0200d9 | Product name | 1 | 20190219 |
| 11ed6f83-cdd2-4637-8379-b1a1d3ae3cde | Product name | 1 | 20181101 |
| 86c45a79-b9f0-4476-a27c-6e10db098497 | Product name | 1 | 20180125 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72789-297-30 | Levothyroxine sodium | 30 in 1 BOTTLE, PLASTIC | TABLET | 30 | 14 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 72789-297-30 | EA - Each | 72789-297 | a38da136-17eb-4375-8b2a-2e1bbeafd9ef | 1 | 2023-02-06 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Preferred Pharmaceuticals Inc. | 4f40db1e-3dd9-4c7b-93e6-64f0fd10d551 | 2026-05-21 | Boxed warning, Warnings, Adverse reactions | 212399 ANDA212399 |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Preferred Pharmaceuticals Inc. | 6d65b528-f52b-4b5d-8b76-46fbd4576f99 | 2026-05-21 | Boxed warning, Warnings, Adverse reactions | 212399 ANDA212399 |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Preferred Pharmaceuticals Inc. | c38c3c31-6834-4590-ace0-f525e5599f66 | 2026-05-20 | Boxed warning, Warnings, Adverse reactions | 212399 ANDA212399 |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Preferred Pharmaceuticals Inc. | 83854522-f22e-491f-8392-c8b1f9441760 | 2026-05-20 | Boxed warning, Warnings, Adverse reactions | 212399 ANDA212399 |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Preferred Pharmaceuticals Inc. | 633b3f9c-9578-4e07-a515-aec1a8b65e92 | 2026-05-19 | Boxed warning, Warnings, Adverse reactions | 212399 ANDA212399 |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Preferred Pharmaceuticals Inc. | 0cffbc96-7a02-4538-9966-b69249be6eb2 | 2026-05-19 | Boxed warning, Warnings, Adverse reactions | 212399 ANDA212399 |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | 775ef7ba-0b5b-40ba-ac7b-2aef121fe4f4 | 2026-05-15 | Boxed warning, Warnings, Adverse reactions | 212399 ANDA212399 |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | 231fcdf8-c642-4074-8be8-53ee9c918f18 | 2026-05-15 | Boxed warning, Warnings, Adverse reactions | 212399 ANDA212399 |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | 251e65e0-6925-4984-9df9-d6d7c6d0703c | 2026-05-15 | Boxed warning, Warnings, Adverse reactions | 212399 ANDA212399 |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | 741a8b30-86e1-4f37-917a-73265a82ee07 | 2026-05-15 | Boxed warning, Warnings, Adverse reactions | 212399 ANDA212399 |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Preferred Pharmaceuticals Inc. | 4a2c8e57-d52d-409f-83d8-731b721bf613 | 2026-04-20 | Boxed warning, Warnings, Adverse reactions | 212399 ANDA212399 |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | f347d92a-7726-4165-bc3c-f5b37ec86f9f | 2026-04-15 | Boxed warning, Warnings, Adverse reactions | 212399 ANDA212399 |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | REMEDYREPACK INC. | f8c14539-8ed1-406a-9b58-8ba3a7ce7ee3 | 2026-04-07 | Boxed warning, Warnings, Adverse reactions | 212399 ANDA212399 |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | REMEDYREPACK INC. | 55cebc88-0514-4940-b974-ec7f0467d10e | 2026-04-06 | Boxed warning, Warnings, Adverse reactions | 212399 ANDA212399 |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | REMEDYREPACK INC. | c7d5b71b-e983-4b1a-bfc2-d2343cf8668c | 2026-04-06 | Boxed warning, Warnings, Adverse reactions | 212399 ANDA212399 |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | a0fa8fa5-d3bd-4e52-9ec5-5fb84702826d | 2026-03-27 | Boxed warning, Warnings, Adverse reactions | 212399 ANDA212399 |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 70853a82-ba3b-4663-9f78-6791ca72ba9f | 2026-03-27 | Boxed warning, Warnings, Adverse reactions | 212399 ANDA212399 |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 7c8a6441-3c12-46ae-bb3b-a320d80045b6 | 2026-03-24 | Boxed warning, Warnings, Adverse reactions | 212399 ANDA212399 |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 008de8fd-150f-4022-8ccb-c8bfa94875c7 | 2026-03-24 | Boxed warning, Warnings, Adverse reactions | 212399 ANDA212399 |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 67f46137-afc4-471b-a6c7-9c2aef92da5d | 2026-03-03 | Boxed warning, Warnings, Adverse reactions | 212399 ANDA212399 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 892246 | levothyroxine sodium 100 MCG Oral Tablet | PSN | 6f4998ac-0714-4f5d-8944-9e6902b9f0a6 | 14 |
| 892246 | levothyroxine sodium 0.1 MG Oral Tablet | SCD | 6f4998ac-0714-4f5d-8944-9e6902b9f0a6 | 14 |
| 892246 | levothyroxine sodium 100 MCG Oral Tablet | SY | 6f4998ac-0714-4f5d-8944-9e6902b9f0a6 | 14 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 72789-297-30 | 72789029730 | 30 TABLET in 1 BOTTLE, PLASTIC (72789-297-30) | 30 tablet | 2023-01-11 | 0000-00-00 | No | No | Current |